The chain of events that P2X7 receptor stimulation may trigger and a detailed understanding of its pathway that covers oxidative stress-innate immune crosstalk may serve as a crucial benchmark in understanding NASH pathophysiology and help design new therapeutic strategies for this metabolic disease (Figure 1). This evidence concerns the gene P2RX7 and Other metabolic disease.